Cargando…

Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission

BACKGROUND: It is unknown if diabetic cats in remission have persistent abnormalities of glucose metabolism and should be considered prediabetic, or have normal glucose tolerance. OBJECTIVE: To characterize glycemic status of diabetic cats in remission and to determine predictors of relapse. ANIMALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottlieb, S., Rand, J.S., Marshall, R., Morton, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858081/
https://www.ncbi.nlm.nih.gov/pubmed/25418027
http://dx.doi.org/10.1111/jvim.12509
_version_ 1782430747565490176
author Gottlieb, S.
Rand, J.S.
Marshall, R.
Morton, J.
author_facet Gottlieb, S.
Rand, J.S.
Marshall, R.
Morton, J.
author_sort Gottlieb, S.
collection PubMed
description BACKGROUND: It is unknown if diabetic cats in remission have persistent abnormalities of glucose metabolism and should be considered prediabetic, or have normal glucose tolerance. OBJECTIVE: To characterize glycemic status of diabetic cats in remission and to determine predictors of relapse. ANIMALS: A total of 21 cats in diabetic remission and 28 healthy control cats. METHODS: At a median of 107 days after remission, screening blood glucose concentration was measured on entry to the clinic. After a 24‐hour fast in hospital, fasting blood glucose, fructosamine and feline pancreatic lipase concentrations were measured, and 3 hours later, a simplified IV glucose tolerance test (1 g glucose/kg) performed. Twenty cats were monitored for relapse for at least 9 months. RESULTS: Of the 21 cats in remission, 19% (4/21) had impaired fasting glucose concentration and 76% (16/21) had impaired glucose tolerance. Of cats followed up for 9 months after testing, 30% (6/20) had relapsed and required insulin treatment. Fasting blood glucose concentration ≥7.5 mmol/L (≥135 mg/dL) (odds ratio [OR] = 12.8) and severely impaired glucose tolerance (≥5 hours to return to <6.5 mmol/L or <117 mg/dL; OR = 15.2) were significantly associated with relapse. Blood glucose concentration >14 mmol/L; 252 mg/dL at 3 hours was significantly associated with relapse (OR = 10.1). CONCLUSION AND CLINICAL IMPORTANCE: Most cats in diabetic remission have impaired glucose tolerance and a minority have impaired fasting glucose concentration and should be considered prediabetic. More severe glucose intolerance and impaired fasting glucose concentration are predictors of relapse. Ongoing glucose monitoring of diabetic cats in remission is recommended.
format Online
Article
Text
id pubmed-4858081
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48580812016-06-22 Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission Gottlieb, S. Rand, J.S. Marshall, R. Morton, J. J Vet Intern Med Standard Articles BACKGROUND: It is unknown if diabetic cats in remission have persistent abnormalities of glucose metabolism and should be considered prediabetic, or have normal glucose tolerance. OBJECTIVE: To characterize glycemic status of diabetic cats in remission and to determine predictors of relapse. ANIMALS: A total of 21 cats in diabetic remission and 28 healthy control cats. METHODS: At a median of 107 days after remission, screening blood glucose concentration was measured on entry to the clinic. After a 24‐hour fast in hospital, fasting blood glucose, fructosamine and feline pancreatic lipase concentrations were measured, and 3 hours later, a simplified IV glucose tolerance test (1 g glucose/kg) performed. Twenty cats were monitored for relapse for at least 9 months. RESULTS: Of the 21 cats in remission, 19% (4/21) had impaired fasting glucose concentration and 76% (16/21) had impaired glucose tolerance. Of cats followed up for 9 months after testing, 30% (6/20) had relapsed and required insulin treatment. Fasting blood glucose concentration ≥7.5 mmol/L (≥135 mg/dL) (odds ratio [OR] = 12.8) and severely impaired glucose tolerance (≥5 hours to return to <6.5 mmol/L or <117 mg/dL; OR = 15.2) were significantly associated with relapse. Blood glucose concentration >14 mmol/L; 252 mg/dL at 3 hours was significantly associated with relapse (OR = 10.1). CONCLUSION AND CLINICAL IMPORTANCE: Most cats in diabetic remission have impaired glucose tolerance and a minority have impaired fasting glucose concentration and should be considered prediabetic. More severe glucose intolerance and impaired fasting glucose concentration are predictors of relapse. Ongoing glucose monitoring of diabetic cats in remission is recommended. John Wiley and Sons Inc. 2014-11-24 2015 /pmc/articles/PMC4858081/ /pubmed/25418027 http://dx.doi.org/10.1111/jvim.12509 Text en Copyright © 2014 by the American College of Veterinary Internal Medicine
spellingShingle Standard Articles
Gottlieb, S.
Rand, J.S.
Marshall, R.
Morton, J.
Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
title Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
title_full Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
title_fullStr Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
title_full_unstemmed Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
title_short Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
title_sort glycemic status and predictors of relapse for diabetic cats in remission
topic Standard Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858081/
https://www.ncbi.nlm.nih.gov/pubmed/25418027
http://dx.doi.org/10.1111/jvim.12509
work_keys_str_mv AT gottliebs glycemicstatusandpredictorsofrelapsefordiabeticcatsinremission
AT randjs glycemicstatusandpredictorsofrelapsefordiabeticcatsinremission
AT marshallr glycemicstatusandpredictorsofrelapsefordiabeticcatsinremission
AT mortonj glycemicstatusandpredictorsofrelapsefordiabeticcatsinremission